ArticleNature communications2021

Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity.

Hema Adhikari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.